Clinical Trial 22573

• Overview

  Study Title:

  A Phase III Randomized Trial of Radiotherapy Optimization for Low-Risk Her2-Positive Breast Cancer (HERO*)

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.